Cargando…
Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis
Chemotherapy resistance of tumor cells causes failure in anti-tumor therapies. Recently, N-terminal regulator of chromatin condensation 1 methyltransferase (NRMT) is abnormally expressed in different cancers. Hence, we speculate that NRMT may pay a crucial role in the development of chemosensitivity...
Autores principales: | Li, Zhongrui, Zhang, Lan, Liu, Dongrui, Yang, Zhanghui, Xuan, Di, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748520/ https://www.ncbi.nlm.nih.gov/pubmed/35013138 http://dx.doi.org/10.1038/s41420-021-00622-w |
Ejemplares similares
-
NRMT is an α-N-methyltransferase that methylates RCC1 and Retinoblastoma Protein
por: Tooley, Christine E. Schaner, et al.
Publicado: (2010) -
Molecular basis for histone N-terminal methylation by NRMT1
por: Wu, Ruoxi, et al.
Publicado: (2015) -
CENPA regulates tumor stemness in lung adenocarcinoma
por: Yu, Qi-Ying, et al.
Publicado: (2022) -
α-amino trimethylation of CENP-A by NRMT is required for full recruitment of the centromere
por: Sathyan, Kizhakke M., et al.
Publicado: (2017) -
Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis
por: Bonsignore, Lindsay A., et al.
Publicado: (2015)